Deborah H. Fuller

7.4k citations

77 papers · 4.2k indexed · 1 hit paper · h-index 31

Co-authors: Joel R. Haynes Harriet L. Robinson Ellen F. Fynan Robert G. Webster J C Santoro Michael D. Eisenbraun James T. Fuller Connie S. Schmaljohn
Topics: HIV Research and Treatment (35 papers)Immunotherapy and Immune Responses (30 papers)Immune Cell Function and Interaction (18 papers)
Cited by: Virology Immunology Infectious Diseases
Journals: New England Journal of Medicine Proceedings of the National Academy of Sciences Nature Communications
Partner nations: United States United Kingdom Cyprus

In The Last Decade

Deborah H. Fuller

76 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations.

1993 901 citations Deborah H. Fuller, Joel R. Haynes et al. profile →

Peers

Countries citing papers authored by Deborah H. Fuller

Since Specialization

Citations

This map shows the geographic impact of Deborah H. Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah H. Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah H. Fuller more than expected).

Fields of papers citing papers by Deborah H. Fuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah H. Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah H. Fuller. The network helps show where Deborah H. Fuller may publish in the future.

Co-authorship network of co-authors of Deborah H. Fuller

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah H. Fuller. A scholar is included among the top collaborators of Deborah H. Fuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah H. Fuller. Deborah H. Fuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Persistent innate immune dysfunction and ZIKV replication in the gastrointestinal tract during SIV infection in pigtail macaques 2025 ·Frontiers in Immunology ·Jennifer Tisoncik-Go,Thomas B. Lewis,Leanne S. Whitmore,(unknown),(unknown),Jin Dai,Paul M. Kim,(unknown),(unknown),(unknown),(unknown),Robert D. Murnane,Paul T. Edlefsen,Kathryn A. Guerriero,Michael Gale,Deborah H. Fuller,Megan A. O’Connor	0
2	SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolution 2025 ·Frontiers in Immunology ·(unknown),(unknown),Adam Waalkes,Kaitlin Sawatzki,Linhui Hao,Dustin R. Long,Kelsi Penewit,Cecily C. Midkiff,(unknown),Simret Beraki,Paul T. Edlefsen,Jane Barrow,Alexander L. Greninger,Michael Gale,Robert V. Blair,Stephen J. Salipante,Deborah H. Fuller,Megan A. O’Connor	1
3	Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina 2023 ·SHILAP Revista de lepidopterología ·Jennifer Tisoncik-Go,(unknown),Thomas B. Lewis,Antonio E. Muruato,LaRene Kuller,Eric Finn,(unknown),(unknown),(unknown),(unknown),Richard Grant,Robert D. Murnane,Paul T. Edlefsen,Deborah H. Fuller,Glen N. Barber,Michael Gale,Megan A. O’Connor	2
4	Rapid progression is associated with lymphoid follicle dysfunction in SIV-infected infant rhesus macaques 2021 ·PLoS Pathogens ·(unknown),(unknown),Adriana Lippy,Brian G. Oliver,(unknown),(unknown),(unknown),(unknown),James T. Fuller,Patience Murapa,(unknown),Maud Mavigner,Ann Chahroudi,D. Noah Sather,Deborah H. Fuller,Donald L. Sodora	5
5	Mucosal T Helper 17 and T Regulatory Cell Homeostasis Correlate with Acute Simian Immunodeficiency Virus Viremia and Responsiveness to Antiretroviral Therapy in Macaques 2018 ·AIDS Research and Human Retroviruses ·Megan A. O’Connor,(unknown),(unknown),(unknown),Thomas B. Lewis,Debbie Bratt,(unknown),Jeremy Smedley,Kenneth Bagley,James I. Mullins,Deborah H. Fuller	9
6	Achieving Potent Autologous Neutralizing Antibody Responses against Tier 2 HIV-1 Viruses by Strategic Selection of Envelope Immunogens 2016 ·The Journal of Immunology ·Ann J. Hessell,Delphine C. Malherbe,Franco Pissani,Sean P. McBurney,Shelly J. Krebs,Michelle M. Gomes,Shilpi Pandey,William F. Sutton,Benjamin J. Burwitz,Matthew D. Gray,Harlan Robins,Byung Park,Jonah B. Sacha,Celia C. LaBranche,Deborah H. Fuller,David C. Montefiori,Leonidas Stamatatos,D. Noah Sather,Nancy L. Haigwood	34
7	Evaluation of protection induced by a dengue virus serotype 2 envelope domain III protein scaffold/DNA vaccine in non-human primates 2016 ·Vaccine ·Sean P. McBurney,(unknown),Sarah Gabriël,Jeremy Huynh,William F. Sutton,Deborah H. Fuller,Nancy L. Haigwood,William B. Messer	25
8	A novel tetrameric gp3501–470 as a potential Epstein–Barr virus vaccine 2013 ·Vaccine ·Xinle Cui,(unknown),Goutam Sen,Gouri Chattopadhyay,Deborah H. Fuller,James T. Fuller,(unknown),Andrew L. Snow,James J. Mond,Clifford M. Snapper	48
9	‘Omics Investigations of HIV and SIV Pathogenesis and Innate Immunity 2012 ·Current topics in microbiology and immunology ·Robert E. Palermo,Deborah H. Fuller	2
10	DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4+ T cells, but few subdominant epitope-specific CD8+ T cells 2011 ·Vaccine ·Lara Vojnov,Alexander T. Bean,Eric Peterson,Marı́a J. Chiuchiolo,Jonah B. Sacha,Ferencz S. Denes,Mátyás Sándor,Deborah H. Fuller,James T. Fuller,Christopher L. Parks,Adrian B. McDermott,Nancy A. Wilson,David I. Watkins	6
11	GM-CSF Increases Mucosal and Systemic Immunogenicity of an H1N1 Influenza DNA Vaccine Administered into the Epidermis of Non-Human Primates 2010 ·PLoS ONE ·Peter T. Loudon,Eric J. Yager,(unknown),Amithi Narendran,(unknown),(unknown),James T. Fuller,P. White,(unknown),Clayton A. Wiley,Michael Murphey‐Corb,Deborah H. Fuller	60
12	Immunogenicity of hybrid DNA vaccines expressing hepatitis B core particles carrying human and simian immunodeficiency virus epitopes in mice and rhesus macaques 2007 ·Virology ·Deborah H. Fuller,Tim Shipley,Todd M. Allen,James T. Fuller,Mary S. Wu,Helen Horton,Nancy A. Wilson,Georg Widera,David I. Watkins	14
13	DNA immunization in combination with effective antiretroviral drug therapy controls viral rebound and prevents simian AIDS after treatment is discontinued 2006 ·Virology ·Deborah H. Fuller,Premeela A. Rajakumar,Mary S. Wu,Christopher W. McMahon,Tim Shipley,James T. Fuller,(unknown),Anita M. Trichel,Todd M. Allen,Bianca R. Mothé,Joel R. Haynes,David I. Watkins,Michael Murphey‐Corb	30
14	Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases 2006 ·Methods ·Deborah H. Fuller,Peter T. Loudon,Connie S. Schmaljohn	117
15	Clinical safety and efficacy of a powdered Hepatitis B nucleic acid vaccine delivered to the epidermis by a commercial prototype device 2005 ·Vaccine ·Lee K. Roberts,(unknown),Deborah H. Fuller,Christopher W. McMahon,Philip T. Leese,Suzanne Jones	38
16	Differences Between T Cell Epitopes Recognized After Immunization and After Infection 2002 ·The Journal of Immunology ·Thorsten U. Vogel,Helen Horton,Deborah H. Fuller,Donald K. Carter,(unknown),David H. O’Connor,Tim Shipley,(unknown),Gerd Sutter,Volker Erfle,Nancy A. Wilson,Louis J. Picker,David I. Watkins	30
17	Induction of AIDS Virus-Specific CTL Activity in Fresh, Unstimulated Peripheral Blood Lymphocytes from Rhesus Macaques Vaccinated with a DNA Prime/Modified Vaccinia Virus Ankara Boost Regimen 2000 ·The Journal of Immunology ·Todd M. Allen,Thorsten U. Vogel,Deborah H. Fuller,Bianca R. Mothé,(unknown),(unknown),Tim Shipley,(unknown),Tomáš Hanke,Alessandro Sette,John D. Altman,Bernard Moss,Andrew J. McMichael,David I. Watkins	213
18	DNA Vaccines Expressing either the GP or NP Genes of Ebola Virus Protect Mice from Lethal Challenge 1998 ·Virology ·L. VanderZanden,Mike Bray,Deborah H. Fuller,(unknown),David Custer,Kristin Spik,Peter B. Jahrling,(unknown),Alan Schmaljohn,Connie S. Schmaljohn	138
19	Use of DNAs Expressing HIV-1 Env and Noninfectious HIV-1 Particles to Raise Antibody Responses in Mice 1995 ·Virology ·Shan Lu,Joseph C. Santoro,Deborah H. Fuller,Joel R. Haynes,Harriet L. Robinson	129
20	A Qualitative Progression in HIV Type 1 Glycoprotein 120-Specific Cytotoxic Cellular and Humoral Immune Responses in Mice Receiving a DNA-Based Glycoprotein 120 Vaccine 1994 ·AIDS Research and Human Retroviruses ·Deborah H. Fuller,Joel R. Haynes	118

About Deborah H. Fuller

Deborah H. Fuller is a scholar working on Virology, Immunology and Infectious Diseases, having authored 77 papers that have together received 4.2k indexed citations. Recurring topics across this work include HIV Research and Treatment (35 papers), Immunotherapy and Immune Responses (30 papers) and Immune Cell Function and Interaction (18 papers). The work is most often cited by research in Virology (1.2k citations), Immunology (2.3k citations) and Infectious Diseases (1.2k citations). Deborah H. Fuller has collaborated with scholars based in United States, United Kingdom and Cyprus. Frequent co-authors include Joel R. Haynes, Harriet L. Robinson, Ellen F. Fynan, Robert G. Webster, J C Santoro, Michael D. Eisenbraun, James T. Fuller, Connie S. Schmaljohn, Dennis E. McCabe and Tamera M. Pertmer. Their work appears in journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact